A GIP agonist, ZP6590 (Zealand Pharma) is currently in a phase 1 trial, and a GLP-1/GIP antagonist, maridebart cafraglutide (formerly AMG 133, Amgen) is currently in phase 2 trials
The same dose in milligrams can require a different number of units if the medication concentration changes
If you see any, tap the barrel firmly with your fingernail until the bubbles rise to the top, then push the plunger gently to expel them
However, it doesn't address the underlying immune dysregulation
Similarly, high concentrations of ions, like the sodium and chloride in saline, can interfere with the hydration shell around the peptide and promote aggregation, where peptide molecules clump together into an inactive, insoluble mass
This partially explains why black market and commercial reports of weight loss with AOD-9604 are anecdotal and uncontrolled, and why the controlled Phase 2b trialwhich used subcutaneous injectionshowed no effect